Advertorial

Market leaders Expo Technologies, Umetrics provide better PAT tool connectivity

0
SHARES

Posted: 18 April 2011 | | No comments yet

Expo Technologies and Umetrics Inc. announce the release of Expo’s NovaMath 5.0…

EXPO_thumb_logo

Expo Technologies (St. Louis, MO) and Umetrics Inc. (San Jose, CA), industry leaders in providing tools for Pharma PAT, announce the release of Expo’s NovaMath 5.0 with capability to use models built in SIMCA- P+ by the SIMCA-QP tool. This capability allows process measurement devices controlled by Expo’s NovaPAC/NovaMath applications to run Umetrics’ SIMCA- P+ models, in real time.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

“The first version of NovaPAC was installed in 2000, before the phrase PAT was even coined, so there are many process spectrometers out there that use Expo’s platform, and these can now access SIMCA-P+’s functionality,” Paul Davies, president of Expo Technologies, explained. “It has always been our goal to provide better inter-connectivity of tools for the Pharmaceutical PAT community, and this latest collaboration between Expo and Umetrics is another step towards that goal.”

SIMCA- P+ multivariate analysis software performs cluster analysis and PLS regression with classification trees. It has full OPLS® and O2PLS® functionalities and improved support for hierarchical PCA and PLS. The analysis of batch data is improved through summarized contribution plots that can be resolved to the level of individual variables.

“There are many improvements in data preprocessing, graphics, and data handling, facilitating the analysis of complex data sets for today’s pharmaceutical PAT processes,” said Lars Lindström, Umetrics general manager.

Related organisations

,

Related people

Share via
Share via